Repligen (RGEN) Common Equity (2016 - 2025)
Repligen (RGEN) has disclosed Common Equity for 16 consecutive years, with $2.1 billion as the latest value for Q4 2025.
- On a quarterly basis, Common Equity rose 6.76% to $2.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 billion, a 6.76% increase, with the full-year FY2025 number at $2.1 billion, up 6.76% from a year prior.
- Common Equity was $2.1 billion for Q4 2025 at Repligen, up from $2.1 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $2.1 billion in Q4 2025 to a low of $1.6 billion in Q1 2021.
- A 5-year average of $1.9 billion and a median of $2.0 billion in 2023 define the central range for Common Equity.
- Peak YoY movement for Common Equity: skyrocketed 52.49% in 2021, then increased 0.4% in 2024.
- Repligen's Common Equity stood at $1.8 billion in 2021, then grew by 9.18% to $1.9 billion in 2022, then grew by 2.83% to $2.0 billion in 2023, then rose by 0.4% to $2.0 billion in 2024, then rose by 6.76% to $2.1 billion in 2025.
- Per Business Quant, the three most recent readings for RGEN's Common Equity are $2.1 billion (Q4 2025), $2.1 billion (Q3 2025), and $2.1 billion (Q2 2025).